EA200000552A1 - Готовые препаративные формы, содержащие растворенный пароксетин - Google Patents

Готовые препаративные формы, содержащие растворенный пароксетин

Info

Publication number
EA200000552A1
EA200000552A1 EA200000552A EA200000552A EA200000552A1 EA 200000552 A1 EA200000552 A1 EA 200000552A1 EA 200000552 A EA200000552 A EA 200000552A EA 200000552 A EA200000552 A EA 200000552A EA 200000552 A1 EA200000552 A1 EA 200000552A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetine
solid
paroxetin
ready
forms containing
Prior art date
Application number
EA200000552A
Other languages
English (en)
Russian (ru)
Inventor
Ахмад Газави
Грэхам Стэнли Леонард
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000552A1 publication Critical patent/EA200000552A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200000552A 1997-11-21 1998-11-18 Готовые препаративные формы, содержащие растворенный пароксетин EA200000552A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (1)

Publication Number Publication Date
EA200000552A1 true EA200000552A1 (ru) 2000-10-30

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000552A EA200000552A1 (ru) 1997-11-21 1998-11-18 Готовые препаративные формы, содержащие растворенный пароксетин

Country Status (24)

Country Link
EP (1) EP1033986A1 (xx)
JP (1) JP2001523718A (xx)
KR (1) KR20010032320A (xx)
CN (1) CN1279608A (xx)
AP (1) AP2000001821A0 (xx)
AR (1) AR015485A1 (xx)
AU (1) AU1168099A (xx)
BG (1) BG104527A (xx)
BR (1) BR9814220A (xx)
CO (1) CO4970832A1 (xx)
DZ (1) DZ2658A1 (xx)
EA (1) EA200000552A1 (xx)
GB (1) GB9724544D0 (xx)
HU (1) HUP0100580A3 (xx)
IL (1) IL136106A0 (xx)
MA (1) MA24704A1 (xx)
NO (1) NO20002590L (xx)
OA (1) OA11385A (xx)
PE (1) PE20000381A1 (xx)
PL (1) PL340555A1 (xx)
SK (1) SK7342000A3 (xx)
TR (1) TR200001423T2 (xx)
WO (1) WO1999026625A1 (xx)
ZA (1) ZA9810637B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
DK1109806T3 (da) 1999-07-01 2003-12-22 Italfarmaco Spa Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
ES2294197T3 (es) * 2001-12-21 2008-04-01 Supernus Pharmaceuticals, Inc. Formulacion de capsula oral con estabilidad fisica aumentada.
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
JP2013512948A (ja) * 2009-12-08 2013-04-18 イル・ファ・カンパニー・リミテッド ２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran

Also Published As

Publication number Publication date
WO1999026625A1 (en) 1999-06-03
BG104527A (en) 2001-04-30
CO4970832A1 (es) 2000-11-07
HUP0100580A2 (hu) 2002-04-29
AR015485A1 (es) 2001-05-02
NO20002590L (no) 2000-07-19
TR200001423T2 (tr) 2000-10-23
SK7342000A3 (en) 2000-12-11
PL340555A1 (en) 2001-02-12
KR20010032320A (ko) 2001-04-16
EP1033986A1 (en) 2000-09-13
HUP0100580A3 (en) 2002-05-28
DZ2658A1 (fr) 2003-03-22
OA11385A (en) 2004-01-27
BR9814220A (pt) 2001-12-26
AP2000001821A0 (en) 2000-06-30
CN1279608A (zh) 2001-01-10
GB9724544D0 (en) 1998-01-21
IL136106A0 (en) 2001-05-20
AU1168099A (en) 1999-06-15
PE20000381A1 (es) 2000-05-07
JP2001523718A (ja) 2001-11-27
NO20002590D0 (no) 2000-05-19
MA24704A1 (fr) 1999-07-01
ZA9810637B (en) 2000-05-22

Similar Documents

Publication Publication Date Title
BR8606835A (pt) Capsulas de gelatina e processo para a sua obtencao
KR880701544A (ko) 이온화 가능한 의약 제제용 용해 시스템
EA200000552A1 (ru) Готовые препаративные формы, содержащие растворенный пароксетин
FR2361914A1 (fr) Nouvelles formulations de medicaments a danger d'emploi abusif reduit
ATE65023T1 (de) Pharmazeutische mittel.
FR2430403A1 (fr) Nouvelles 15-deoxy-16-hydroxy-prostaglandines, leur procede de production et medicament les contenant
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
BR9509550A (pt) Formulações de ciclosporina para administração oral com composição simples e alta biodisponibilidade e processo para sua produção
GT198303076A (es) Formulaciones de pastillas de accion prolongada con disolucion paulatina.
SV2002000969A (es) Composicion parenteral reconstituible
KR830005854A (ko) 알카리성 진통제 캡슐의 제조방법
IT1240768B (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
PE10396A1 (es) Formulacion farmaceutica administrada oralmente
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
FI913409A0 (fi) Menetelmä vaikuttavana aineena mesnaa sisältävien tablettien ja granulaatin valmistamiseksi
ES2127305T3 (es) Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos.
GT199000039A (es) Compuestos heterociclicos.
GB1110397A (en) Ephedrine composition
ES419603A1 (es) Procedimiento para la produccion de tabletas mecanicamente estables y resistentes que contienen una o varias pirazolo- nas y eventualmente compuestos de cafeina.
CO4520304A1 (es) Dihidrato de eprosartano y un procedimiento para su produc- cion y formulacion
ES2068154B1 (es) Nuevas formulaciones analgesicas con amplio intervalo de accion.
MX9704847A (es) Material de relleno para forma de dosis farmaceutica de gelatina blanda.
TH18778A (th) สูตรผสมสำหรับสารทางเคมีเภสัชศาสตร์ที่ให้ทางปาก
AR013140A1 (es) Uso de un agente que se une al receptor de estrogenos para la preparacion de un medicamento util para tratar los sintomas de memoria, concentracion yconocimiento deteriorados en mujeres postmenopausicas
GT199800036A (es) Nuevas formulaciones farmaceuticas en forma seca para administracion oral, que contienen como principio activo, uncompuesto de amonio cuaternario ciclico.